Schalm SW - Search Results

1

Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.

Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van Dekken H. Zondervan PE, et al. Among authors: schalm sw. J Pathol. 2000 Oct;192(2):207-15. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH690>3.0.CO;2-#. J Pathol. 2000. PMID: 11004697

2

Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation.

Hussain SM, Zondervan PE, IJzermans JN, Schalm SW, de Man RA, Krestin GP. Hussain SM, et al. Among authors: schalm sw. Radiographics. 2002 Sep-Oct;22(5):1023-36; discussion 1037-9. doi: 10.1148/radiographics.22.5.g02se061023. Radiographics. 2002. PMID: 12235331 Review.

3

Long-term application of human polyclonal hepatitis-B immunoglobulin to prevent hepatic allograft infection. A review of the literature and presentation of five cases.

de Man RA, Metselaar HJ, Heijtink RA, Schalm SW. de Man RA, et al. Among authors: schalm sw. Neth J Med. 1993 Aug;43(1-2):74-82. Neth J Med. 1993. PMID: 8232699 Review.

4

Survival and complications in a cohort of patients with anti-delta positive liver disease presenting in a tertiary referral clinic.

de Man RA, Sprey RP, Niesters HG, Heijtink RA, Zondervan PE, Hop W, Schalm SW. de Man RA, et al. Among authors: schalm sw. J Hepatol. 1995 Dec;23(6):662-7. doi: 10.1016/0168-8278(95)80031-x. J Hepatol. 1995. PMID: 8750164

5

Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine.

Honkoop P, de Man RA, Zondervan PE, Schalm SW. Honkoop P, et al. Among authors: schalm sw. Liver. 1997 Apr;17(2):103-6. doi: 10.1111/j.1600-0676.1997.tb00789.x. Liver. 1997. PMID: 9138281 Clinical Trial.

6

Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B.

Honkoop P, de Man RA, Scholte HR, Zondervan PE, Van Den Berg JW, Rademakers LH, Schalm SW. Honkoop P, et al. Among authors: schalm sw. Hepatology. 1997 Jul;26(1):211-5. doi: 10.1002/hep.510260128. Hepatology. 1997. PMID: 9214472 Clinical Trial.

7

Review article: glycyrrhizin as a potential treatment for chronic hepatitis C.

van Rossum TG, Vulto AG, de Man RA, Brouwer JT, Schalm SW. van Rossum TG, et al. Among authors: schalm sw. Aliment Pharmacol Ther. 1998 Mar;12(3):199-205. doi: 10.1046/j.1365-2036.1998.00309.x. Aliment Pharmacol Ther. 1998. PMID: 9570253 Review.

8

Antiviral treatment for human immunodeficiency virus patients co-infected with hepatitis B virus: combined effect for both infections, an obtainable goal?

Wolters LM, Niesters HG, de Man RA, Schalm SW. Wolters LM, et al. Among authors: schalm sw. Antiviral Res. 1999 May;42(1):71-6. doi: 10.1016/s0166-3542(99)00016-9. Antiviral Res. 1999. PMID: 10333144

9

Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy.

Honkoop P, de Man RA, Niesters HG, Zondervan PE, Schalm SW. Honkoop P, et al. Among authors: schalm sw. Hepatology. 2000 Sep;32(3):635-9. doi: 10.1053/jhep.2000.16333. Hepatology. 2000. PMID: 10960461

10

Combination and newer therapies for chronic hepatitis B.

Schalm SW, De Man RA, Janssen HL. Schalm SW, et al. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S338-41. doi: 10.1046/j.1440-1746.17.s3.24.x. J Gastroenterol Hepatol. 2002. PMID: 12472960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters